#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

byTeddy Guo

July 8, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

RelatedReports

Oncology

Patients with HER2-positive advanced breast cancer and pathological complete response to neoadjuvant systemic therapy may not require surgical intervention

October 31, 2022

StudyGraphics

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

October 25, 2022

StudyGraphics

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

October 19, 2022

StudyGraphics

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

October 18, 2022

Celiac disease more prevalent in children with irritable bowel syndrome

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

Incidental findings common with breast imaging, often benign

Tamoxifen decreases recurrence rates at 25 years in lymph node-negative estrogen-receptor-positive and Erb-B2 Receptor Tyrosine Kinase 2-negative breast cancer

Active smoking cessation intervention may provide tangible results [Project CLIQ]

Systematic analysis of tobacco smoking prevalence in 204 countries from 1990 to 2019

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

Patients with HER2-positive advanced breast cancer and pathological complete response to neoadjuvant systemic therapy may not require surgical intervention

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

RelatedReports

Patients with HER2-positive advanced breast cancer and pathological complete response to neoadjuvant systemic therapy may not require surgical intervention

#VisualAbstract: Intensity-modulated radiotherapy alone is noninferior to concurrent chemoradiotherapy for low-risk nasopharyngeal carcinoma

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

Tamoxifen decreases recurrence rates at 25 years in lymph node-negative estrogen-receptor-positive and Erb-B2 Receptor Tyrosine Kinase 2-negative breast cancer

Systematic analysis of tobacco smoking prevalence in 204 countries from 1990 to 2019

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

RELATED REPORTS

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?